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Abstract
Background Palliative irreversible electroporation of pan-
creatic adenocarcinomas is rapidly gaining in interest since
a large proportion of these patients cannot be radically
resected.
Methods This is a description of a minimally invasive
approach to irreversible electroporation of pancreatic
tumors using computer-assisted navigation, laparoscopy
and laparoscopic ultrasound to correctly guide electrodes
into the tissue.
Results The procedure is presented.
Conclusion Minimally invasive irreversible electropora-
tion of pancreatic tumors through computer-assisted navi-
gation of needles during laparoscopy is a feasible and
accurate approach.
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Background
Pancreatic cancer accounts for 4 % of cancer deaths
worldwide and is on the trajectory of becoming the second
leading cause of cancer-related deaths in the USA by 2030.
Fifty percent of patients will have a disseminated disease at
the time of diagnosis [1]. In patients with localized tumors,
approximately 20 % are resectable with a disappointing
5-year survival of 20–25 % being reported [2, 3]. The
remaining patients receive oncologic treatment (down-
staging or palliative) or best supportive care, with a dismal
5-year survival of around 2 % [4].
Resection of tumors in the head of the pancreas involves
major surgery with resection of the pancreas, duodenum,
distal bile duct and often part of the stomach, and in
selected cases, resection of vascular structures involved
[5]. Postoperative morbidity is high, and problems such as
delayed gastric emptying are common [6].
Alternative means for local treatment has been investi-
gated, including radiation therapy and a variety of thermal
and non-thermal local ablation techniques generally with
discouraging results [7–9]. Thermal options are problem-
atic because of the proximity of vital vasculature structures
and pancreatic and bile ducts, all being sensitive to thermal
ablation. Irreversible electroporation (IRE) is a relatively
new method for local treatment, achieving cell death by the
application of short electrical pulses (millisecond pulses
with field strengths of up to 1500 V/cm) while causing
minimal thermal effects on connective tissue. Vascular and
ductal structures are there for generally spared. Promising
results have been reported for IRE as an adjuvant to
chemotherapy, almost doubling median survival in pallia-
tive patients and increasing resection margins in resections
with curative intent [10]. The IRE electrodes are applied
during open surgery or percutaneously using ultrasound
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guidance. Problems with these approaches include trauma
caused by the laparotomy and avoiding damage to sur-
rounding organs, especially with the percutaneous
approach.
In an effort to address these issues, a laparoscopic
approach has been developed using 3D mapping of rele-
vant structures, computer-assisted navigation and laparo-
scopic ultrasound.
Methods
Patients were all presented at a pancreas multidisciplinary
team (MDT) conference, and the possibility of curative
surgery was ruled out. They were referred for palliative
chemotherapy and on patient demand assessed for IRE
ablation. In patients, deemed suitable for treatment, the
experimental nature of the treatment was explained and
written consent obtained.
Only patients with localized disease without any signs
of metastases were included. Procedures were performed
under general anesthesia with a complete neuromuscular
block to reduce muscle contractions caused by the strong
electrical pulses administered. A 3D anatomical map,
constructed from a 3-phase preoperative CT scan using
dedicated software (MeVis AG, Bremen, Germany), was
loaded into the CAS-One navigation system (Cascination
AG, Bern, Switzerland), consisting of a computer with a
stereotactic infrared camera and dedicated navigational
software developed for open liver surgery [11]. Using
ultrasonic energy (Harmonic ACE, Ethicon Endo-surgery,
USA), the gastrocolic ligament was opened along the
greater curvature of the stomach right up to the pylorus.
The stomach was displaced cephalad, and the ventral
aspect of the pancreas visualized. Four-point matching
with the 3D model was performed using a rigid pointing
instrument for acquiring anatomical structures around the
tumor which were directly visible or identifiable on
ultrasound. The formation pattern for the IRE needles was
designed based on tumor-specific properties with con-
sideration of surrounding structures. Needles were inser-
ted into the abdominal cavity through coaxial stabilizing
needles and advanced into the pancreatic tissue at a point
defined using the rigid pointer and to a depth indicated by
the navigational software that recognizes reflective
spheres on a marker shield attached to the handle of the
IRE needle. Laparoscopic ultrasound was used to ascer-
tain optimal needle positioning, for example, by visual-
izing the superior mesenteric artery and placing needles
on each side to ablate tumorous tissue around the artery.
After application of the calculated ablation energy,




A 75-year-old woman with an initially 30-mm pancreatic
adenocarcinoma surrounding the superior mesenteric artery
was treated after a response on chemotherapy (10-mm
shrinkage) was achieved. Surgery took 190 min, and the
patient was discharged after 12 days. The postoperative
period was complicated by an acute fluid collection which
was drained percutaneously and vanished. Postoperative
imaging after 8 months showed a stable 25-mm lesion and
up to 8-mm-large lymph nodes in the vicinity, a situation
that has remained unchanged for the subsequent 6 months
(Fig. 2).
Patient 2
A 64-year-old man with a 35-mm pancreatic adenocarci-
noma surrounding the superior mesenteric artery was
treated after 1-year chemotherapy treatment resulted in
stable disease. Surgery took 156 min, and the patient was
discharged after 5 days. The postoperative course was
uneventful. Postoperative imaging at 6 months showed a
diffused perivascular infiltration with subsequent growth
observed at the tumor site, measuring 30 9 80 mm at one-
year follow-up. After 14 months, the patient is still alive
and under palliative care (Fig. 3).
Patient 3
A 78-year-old woman with a 50 9 45 mm pancreatic
adenocarcinoma surrounding the superior mesenteric
artery, engaging most of the uncinate process, was treated.
The duration of surgery was 282 min of which the treat-
ment took 160 min. The postoperative period was com-
plicated by pancreatitis with acute fluid collections and
spondylodiscitis affecting the epidural space. On day 6,
there was a small duodenal perforation that was success-
fully covered by a covered stent. Postoperative imaging has
shown complete ablation of the tumor, and the patient
could after 100 days of hospice care return home. After
146 days, the patient is cared for in her home with minimal
discomfort, but a new CT scan has showed recurrent tumor,
and palliative chemotherapy is planned (Fig. 4).
Discussion
We present a novel method for minimally invasive irre-
versible electroporation in the palliative treatment of pan-
creatic tumors. The present work describes a workflow for
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virtual 3D treatment planning and computer-assisted nav-
igation for guidance of electrode placement, which was
successfully implemented on three patients. We believe
that computer-assisted navigation improves orientation in
the complex vascular settings, enabling IRE treatment with
a laparoscopic approach.
Although this technique offers minimal trauma for the
access, the ablative treatment in itself can cause severe
local trauma to the tumor and surrounding pancreatic tissue
with resulting secondary pancreatitis associated with
postoperative pain, fluid collections and pseudocyst for-
mation that need to be managed as in any pancreatitis.
A randomized controlled study examining the efficacy
of the addition of minimally invasive IRE to standard
chemotherapy of primarily inoperable localized pancreatic
tumors is planned.
A 3D-PDF file is included and is the 3D reconstruction for
the third patient with the resulting ablated volume overlaid and
an approximation of the needle configuration used. The file
must be opened in Adobe Acrobat Reader to work properly.
Fig. 1 Patient setup with CAS-One on the patients right with twin
infrared cameras and laparoscopic screen and ultrasound screen on
the left. A On-screen image of rendered abdominal structures in the
MeVis model. B Laparoscopic port placements and site of IRE needle
entries. C Laparoscopic view of laparoscopic ultrasound device
aligned over the superior mesenteric artery and IRE needles inserted
in a 2 9 3 fashion to surround the tumor. D Setup of surgeons and
monitors
Fig. 2 3D reconstruction of preoperative CT-scan for patient 1 Fig. 3 3D reconstruction of preoperative CT-scan for patient 2
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